Shroff, R., and Rees, L.: The post-transplant lymphoproliferative disorder—a literature review. Pediatr. Nephrol. 2004, 19:369–377.
Wang, H.Y., Lee, D.A., Peng, G., Guo, Z., Li, Y., Kiniwa, Y., Shevach, E.M., and Wang, R.F.: Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 2004, 20:107–118.
16-15 Tumor rejection antigens can be recognized by T cells and form the basis of immunotherapies.
Clark, R.E., Dodi, I.A., Hill, S.C., Lill, J.R., Aubert, G., Macintyre, A.R., Rojas, J., Bourdon, A., Bonner, P.L., Wang, L., et al.: Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood 2001, 98:2887–2893.
Comoli, P., Pedrazzoli, P., Maccario, R., Basso, S., Carminati, O., Labirio, M., Schiavo, R., Secondino, S., Frasson, C., Perotti, C., et al.: Cell therapy of Stage IV nasopharyngeal carcinoma with autologous Epstein–Barr virus-targeted cytotoxic T lymphocytes. J. Clin. Oncol. 2005, 23:8942–8949.
Disis, M.L., Knutson, K.L., McNeel, D.G., Davis, D., and Schiffman, K.: Clinical translation of peptide-based vaccine trials: the HER-2/neu model. Crit. Rev. Immunol. 2001, 21:263–273.
Dudley, M.E., Wunderlich, J.R., Yang, J.C., Sherry, R.M., Topalian, S.L., Restifo, N.P., Royal, R.E., Kammula, U., White, D.E., Mavroukakis, S.A., et al.: Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol. 2005, 23:2346–2357.
Matsushita, H., Vesely, M.D., Koboldt, D.C., Rickert, C.G., Uppaluri, R., Magrini, V.J., Arthur, C.D., White, J.M., Chen, Y.S., Shea, L.K., et al.: Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 2012, 482:400–404.
Michalek, J., Collins, R.H., Durrani, H.P., Vaclavkova, P., Ruff, L.E., Douek, D.C., and Vitetta, E.S.: Definitive separation of graft-versus-leukemiaand graft-versus-host-specific CD4+ T cells by virtue of their receptor β loci sequences. Proc. Natl Acad. Sci. USA 2003, 100:1180–1184.
Morris, E.C., Tsallios, A., Bendle, G.M., Xue, S.A., and Stauss, H.J.: A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection. Proc. Natl Acad. Sci. USA 2005, 102:7934–7939.